LabCorp strengthens its CRO standing with $1.2B Chiltern acquisition
LabCorp, a provider of clinical laboratory products and services, is acquiring CRO Chiltern International in order to scale up their life science capabilities.
The deal has an enterprise value of $1.2B and adds about 4,500 people to LabCorp’s CRO workforce, with roughly 2,000 employees based in the Americas, 1,800 in Europe and 700 in the Asian-Pacific region – increasing the Asia-Pacific employee count more than 40% to 2,400.
